SILREAL

SILREAL GmbH is a strategic advisory firm operating at the intersection of healthcare policy, regulation, and cross-border market access. We support pharma, biotech, medtech, and healthcare investors in navigating high-stakes regulatory and political environments across Europe, China, and the United States. Our core work focuses on: • Policy-driven market access (EU, China, US) • Government affairs & regulatory intelligence • Cross-border partnerships and licensing • Health system integration & procurement strategy SILREAL is trusted by global life sciences leaders, including AstraZeneca, Bayer, Roche, Sartorius, and public institutions such as the German Federal Ministry of Health and EU-level bodies. What differentiates us: • We translate policy signals into commercial decisions • We operate as a risk filter for C-level and Boards • We design mandate-led EU–China partnerships with real execution power SILREAL is not a market research firm. We work on retainer-based strategic mandates where regulatory, political, and industrial policy directly impact revenue, investment, and long-term positioning. Typical clients: CEOs, CSOs, Heads of Global Policy, Market Access, Corporate Strategy, BD, and Healthcare Investors. Focus sectors: Pharma • Biotech • Medtech • Digital Health • Health AI • Healthcare Infrastructure 🌍 Europe | China | United States 📍 Headquarters: Berlin 🔗 www.silreal.com